Mankyu Park

Directeur/Bestuurslid bij

Coagulant Therapeutics, Inc.

Consumer Services

Finance

Health Technology

Profiel

Mankyu is a Principal at DTCP in the Growth Equity team and covers Korea-based investments.
Mankyu came to DTCP from L&S Venture Capital, a leading Korean VC specializing in IT, semiconductors, and display investments.
Prior to that he held positions in the investment banking division of KB Securities and at Partners Group.
Mankyu made investments in IT, AI, Bio/Life science, mobile platforms, and other tech sectors.
Mankyu also led a couple of mid-to-large size deals like Youngin Engineering and Coagulant Therapeutics where top-tier Korean local VCs participated.
Mankyu holds a bachelor’s degree in business administration with concentration on finance from Goizueta Business School, Emory University.

Actieve functies van Mankyu Park

Bedrijven	Functie	Begin
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Directeur/Bestuurslid	-

Alle actieve functies van Mankyu Park

Eerdere bekende functies van Mankyu Park

Bedrijven	Functie	Einde
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	-

Ervaring van Mankyu Park in detail bekijken

Opleiding van Mankyu Park

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mankyu Park in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	3
Goizueta Business School-Emory Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Finance
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Health Technology